Market Overview

Flu Activity Continues to Rise, Related Prescriptions Up 12% from Last Week; Watch CVS, Walgreen

Related CVS
Top 4 Stocks In The Health Care Plans Industry With The Highest Revenue
Retail ETFs Hitting Highs Ahead Of Holidays
Making Money With Charles Payne: 11/24/14 (Fox Business)
Related WAG
Will YouTube's Subscription Music Service Be Profitable?
Tigress Financial Reiterates On Walgreens
Making Money With Charles Payne: 10/22/14 (Fox Business)

Lazard Capital Market's Tom Galluci issued an update on flu activity Monday morning following a note from December 17th which suggested CVS (NYSE: CVS) and Walgreen (NYSE: WAG) could benefit from increased cases of the virus.

The analyst said flu activity was up 12 percent from last week and up a very concerning 94 percent from the same week last year. Prescriptions for cold, cough and/or flu drugs has surged 61 percent from December 2011.

Galluci believes this increase in activity is likely to have a greater effect on hospital volume metrics rather than earnings as a lower-margin business.

Lazard maintains a Buy rating on CVS and a Neutral rating on Walgreen shares.

Latest Ratings for CVS

DateFirmActionFromTo
Nov 2014Deutsche BankMaintainsHold
Nov 2014FBR CapitalMaintainsOutperform
Sep 2014Cowen & CompanyUpgradesMarket PerformOutperform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings

 

Related Articles (CVS + RAD)

Around the Web, We're Loving...

Get Benzinga's Newsletters